Atlas Trials

A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Clinical trial NCT00002236 · COMPLETED

Trial details

NCT number
NCT00002236
Sponsor
Pharmacia and Upjohn
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
HIV Infections
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.